Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
18 hedge funds and large institutions have $26M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
7.23% more ownership
Funds ownership: 29.63% → 36.86% (+7.2%)
10% less funds holding
Funds holding: 20 → 18 (-2)
28% less capital invested
Capital invested by funds: $36.1M → $26M (-$10.1M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
+$1.22M |
| 2 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$1.15M |
| 3 |
Morgan Stanley
New York
|
+$178K |
| 4 |
Renaissance Technologies
New York
|
+$42.5K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$27.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$1.88M |
| 2 |
Axa
Paris,
France
|
-$769K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$668K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$613K |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$413K |
FRLN Hedge Fund Activity: Q4 2021 in Review
18 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q4 2021, worth a combined $26M — down 28% from $36.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FRLN and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was CHI Advisors, adding an estimated $1.22M. The largest seller was Frazier Management, exiting entirely with an estimated $1.88M sold.
- 18 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q4 2021, down from 20 in Q3 2021.
- Funds reported $26M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q4 2021, down 28% quarter-over-quarter.
- 2 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q4 2021 and 4 closed out, a net change of -2 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q4 2021 was CHI Advisors, an estimated $1.22M added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q4 2021 was Frazier Management, an estimated $1.88M sold.
Based on aggregated 13F filings for Q4 2021.